rs786200904
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_005055.5(RAPSN):c.553_554insGTTCT(p.Phe185CysfsTer20) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000889 in 1,461,878 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000089 ( 0 hom. )
Consequence
RAPSN
NM_005055.5 frameshift
NM_005055.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 8.87
Genes affected
RAPSN (HGNC:9863): (receptor associated protein of the synapse) This gene encodes a member of a family of proteins that are receptor associated proteins of the synapse. The encoded protein contains a conserved cAMP-dependent protein kinase phosphorylation site, and plays a critical role in clustering and anchoring nicotinic acetylcholine receptors at synaptic sites by linking the receptors to the underlying postsynaptic cytoskeleton, possibly by direct association with actin or spectrin. Mutations in this gene may play a role in postsynaptic congenital myasthenic syndromes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Apr 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
?
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
?
Very rare variant in population databases, with high coverage;
PP5
?
Variant 11-47442792-A-AAGAAC is Pathogenic according to our data. Variant chr11-47442792-A-AAGAAC is described in ClinVar as [Likely_pathogenic]. Clinvar id is 8048.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RAPSN | NM_005055.5 | c.553_554insGTTCT | p.Phe185CysfsTer20 | frameshift_variant | 3/8 | ENST00000298854.7 | |
LOC124902673 | XR_007062669.1 | n.145-4532_145-4528dup | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RAPSN | ENST00000298854.7 | c.553_554insGTTCT | p.Phe185CysfsTer20 | frameshift_variant | 3/8 | 1 | NM_005055.5 | P1 | |
RAPSN | ENST00000352508.7 | c.553_554insGTTCT | p.Phe185CysfsTer20 | frameshift_variant | 3/6 | 1 | |||
RAPSN | ENST00000529341.1 | c.553_554insGTTCT | p.Phe185CysfsTer20 | frameshift_variant | 3/5 | 1 | |||
RAPSN | ENST00000524487.5 | c.532-872_532-871insGTTCT | intron_variant | 5 |
Frequencies
GnomAD3 genomes ? Cov.: 33
GnomAD3 genomes
?
Cov.:
33
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461878Hom.: 0 Cov.: 34 AF XY: 0.0000110 AC XY: 8AN XY: 727238
GnomAD4 exome
AF:
AC:
13
AN:
1461878
Hom.:
Cov.:
34
AF XY:
AC XY:
8
AN XY:
727238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? Cov.: 33
GnomAD4 genome
?
Cov.:
33
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
RAPSN-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 15, 2022 | The RAPSN c.549_553dup5 variant is predicted to result in a frameshift and premature protein termination (p.Phe185Cysfs*20). This variant was reported in the compound heterozygous state in patients with congenital myasthenic syndrome (variant referred to as 553ins5 in Patient 4, Ohno et al. 2002. PubMed ID: 11791205; variant referred to as 551ins5 in patients 2 and 5, Burke et al. 2003. PubMed ID: 14504330). Functional analysis showed that this variant impacted recruitment of the acetylcholine receptor to rapsyn clusters (Ohno et al. 2002. PubMed ID: 11791205). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in RAPSN are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
Fetal akinesia deformation sequence 1;C4225367:Congenital myasthenic syndrome 11 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Nov 03, 2022 | This premature translational stop signal has been observed in individual(s) with congenital myasthenic syndrome (PMID: 11791205). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Experimental studies have shown that this premature translational stop signal affects RAPSN function (PMID: 11791205). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 8048). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Phe185Cysfs*20) in the RAPSN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RAPSN are known to be pathogenic (PMID: 17686188). - |
Fetal akinesia deformation sequence 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 10, 2024 | - - |
Congenital myasthenic syndrome 11 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2002 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at